Clearfield (NASDAQ:CLFD) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
Analysts have recently evaluated Clearfield and provided 12-month price targets. The average target is $47.5, accompanied by a high estimate of $50.00 and a low estimate of $45.00. Observing a 6.15% increase, the current average has risen from the previous average price target of $44.75.
Understanding Analyst Ratings: A Comprehensive Breakdown
The standing of Clearfield among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Ryan Koontz | Needham | Maintains | Buy | $50.00 | $50.00 |
| Ryan Koontz | Needham | Raises | Buy | $50.00 | $42.00 |
| Tim Savageaux | Northland Capital Markets | Raises | Outperform | $45.00 | $40.00 |
| Scott Searle | Roth MKM | Lowers | Buy | $45.00 | $47.00 |
Key Insights:
For valuable insights into Clearfield's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Clearfield analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Discovering Clearfield: A Closer Look
A Deep Dive into Clearfield's Financials
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Decline in Revenue: Over the 3 months period, Clearfield faced challenges, resulting in a decline of approximately -20.38% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Clearfield's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.92% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Clearfield's ROE excels beyond industry benchmarks, reaching -0.16%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Clearfield's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -0.14%, the company showcases efficient use of assets and strong financial health.
Debt Management: Clearfield's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.07.
Analyst Ratings: Simplified
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
